Appointment of Dr. Mohan Lal Gandhi as Non-Executive Independent Director of the Company for the period of 5 Years
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Dr Lalchandani Labs Ltd, at its meeting on September 5, 2025, approved several items including the 08th Annual Report and notice for the AGM scheduled for September 30, 2025 in New Delhi. The board appointed Mr. Mohan Lal Gandhi (DIN: 00800786) as a Non-Executive Independent Director for a 5-year term from September 5, 2025 to September 04, 2030. Mr. Gandhi is a physician (MBBS) with prior board experience and served as President of a Chamber of Commerce for two years. The board also approved increasing the authorized share capital from Rs. 4.50 crore to Rs. 11 crore, a rise of Rs. 6.50 crore, and appointed M/s. Chauhan Pradeep & Associates as Secretarial Auditor for 5 years (FY2025-26 to FY2029-30).
For shareholders, this is largely routine governance housekeeping. The authorized capital increase signals potential fundraising plans ahead, which could lead to dilution. The addition of an experienced independent director and a long-tenure secretarial auditor should be viewed neutrally as standard compliance measures.